November 22, 2022 – Stomach Cancer Is Still a Risk for Many People

Stomach cancer isn’t in the spotlight like other cancers, such as breast and colon cancers. Once the leading cause of cancer deaths in the United States, stomach cancer, also known as gastric cancer, has declined steadily over the past century. Today, stomach cancer accounts for about 1.5% of all new cancers in the U.S. each…

Read More

November 17, 2022 – Astellas Announces Zolbetuximab Meets Primary Endpoint in Phase 3 SPOTLIGHT Trial as First-Line Treatment in Claudin 18.2 Positive, HER2-Negative Locally Advanced or Metastatic Gastric and Gastroesophageal Junction (GEJ) Cancers

TOKYO, November 17, 2022 – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced positive topline results from the Phase 3 SPOTLIGHT clinical trial evaluating the efficacy and safety of zolbetuximab in combination with mFOLFOX6 (a combination regimen that includes oxaliplatin, leucovorin and fluorouracil). Zolbetuximab is an investigational first-in-class monoclonal…

Read More

November 8, 2022 – The Role of H. pylori in Gastric Cancer

Newswise — Helicobacter pylori (H. pylori) infection is a major cause of gastric cancer, and researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have several projects underway to better understand the association and develop much-needed prevention and treatment. Read more >

Read More

October 30, 2022 – Talking About Grief with Anderson Cooper

When the CNN anchor Anderson Cooper was ten, he lost his father, Wyatt, to heart disease; when he was twenty-one, his older brother Carter died by suicide. In 2019, his mother, the artist, and clothing designer Gloria Vanderbilt, passed away at ninety-five, of stomach cancer. (Vanderbilt had watched, desperate and helpless, as Carter leapt from…

Read More